Ye LC - Search Results

1

Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.

Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, Ye QH, Yu Y, Xu B, Qin XY, Xu J. Ye LC, et al. Among authors: ye qh. J Clin Oncol. 2013 Jun 1;31(16):1931-8. doi: 10.1200/JCO.2012.44.8308. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569301 Clinical Trial.

2

Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting.

Zhu D, Zhong Y, Wu H, Ye L, Wang J, Li Y, Wei Y, Ren L, Xu B, Xu J, Qin X. Zhu D, et al. J Surg Res. 2013 Oct;184(2):861-6. doi: 10.1016/j.jss.2013.04.065. Epub 2013 May 18. J Surg Res. 2013. PMID: 23721930

3

Reply to Y. Sunakawa et al and P. Mroczkowski et al.

Ye LC, Zhong YS, Lin Q, Xu J. Ye LC, et al. J Clin Oncol. 2013 Dec 10;31(35):4474-5. doi: 10.1200/JCO.2013.52.4553. Epub 2013 Oct 28. J Clin Oncol. 2013. PMID: 24166525 No abstract available.

4

Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

Zhu D, Zhong Y, Wei Y, Ye L, Lin Q, Ren L, Ye Q, Liu T, Xu J, Qin X. Zhu D, et al. PLoS One. 2014 Jan 21;9(1):e86543. doi: 10.1371/journal.pone.0086543. eCollection 2014. PLoS One. 2014. PMID: 24466143 Free PMC article.

5

MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1α (FIH-1).

Chen T, Yao LQ, Shi Q, Ren Z, Ye LC, Xu JM, Zhou PH, Zhong YS. Chen T, et al. Among authors: ye lc. Cancer Biol Ther. 2014 May;15(5):516-23. doi: 10.4161/cbt.28017. Epub 2014 Feb 12. Cancer Biol Ther. 2014. PMID: 24521875 Free PMC article.

6

Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.

Feng QY, Wei Y, Chen JW, Chang WJ, Ye LC, Zhu DX, Xu JM. Feng QY, et al. Among authors: ye lc. World J Gastroenterol. 2014 Apr 21;20(15):4263-75. doi: 10.3748/wjg.v20.i15.4263. World J Gastroenterol. 2014. PMID: 24764664 Free PMC article. Review.

7

Primary colonic melanoma presenting as ileocecal intussusception: case report and literature review.

Li WX, Wei Y, Jiang Y, Liu YL, Ren L, Zhong YS, Ye LC, Zhu DX, Niu WX, Qin XY, Xu JM. Li WX, et al. Among authors: ye lc. World J Gastroenterol. 2014 Jul 28;20(28):9626-30. doi: 10.3748/wjg.v20.i28.9626. World J Gastroenterol. 2014. PMID: 25071362 Free PMC article. Review.

8

Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable--a meta-analysis.

Feng Q, Wei Y, Zhu D, Ye L, Lin Q, Li W, Qin X, Lyu M, Xu J. Feng Q, et al. PLoS One. 2014 Aug 5;9(8):e104348. doi: 10.1371/journal.pone.0104348. eCollection 2014. PLoS One. 2014. PMID: 25093337 Free PMC article.

9

Determinants of long-term outcome in patients undergoing simultaneous resection of synchronous colorectal liver metastases.

Lin Q, Ye Q, Zhu D, Wei Y, Ren L, Ye L, Feng Q, Xu P, Zheng P, Lv M, Fan J, Xu J. Lin Q, et al. PLoS One. 2014 Aug 27;9(8):e105747. doi: 10.1371/journal.pone.0105747. eCollection 2014. PLoS One. 2014. PMID: 25162714 Free PMC article.

10

Impact of early tumor shrinkage on clinical outcome in wild-type-KRAS colorectal liver metastases treated with cetuximab.

Ye LC, Wei Y, Zhu DX, Chen T, Xu J. Ye LC, et al. J Gastroenterol Hepatol. 2015 Apr;30(4):674-9. doi: 10.1111/jgh.12847. J Gastroenterol Hepatol. 2015. PMID: 25387601 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters